Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back-and front-of-the-eye in order to improve the sight and the lives of patients worldwide.

Biotechnology

Oculis

Riad Sherif

Snehal Shah

Virginia R. Dean

Kate Allman

Louie Anne Gauthier

Rebecca Weil

Gudrun Bachmann

Einar Stefansson

David Jacobs

Páll Ragnar Jóhannesson

Sylvia Cheung

Gudrun M. Asgrimsdottir

Scientific Advisors and Research Scientists

Leadership Team

Financial Management and Analysis

Clinical Operations and Development

Teams at Oculis

Scientific Advisors and Research Scientists

Leadership Team

Financial Management and Analysis

Clinical Operations and Development